Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders
Breno Satler Diniz,1 Rodrigo Machado-Vieira,2,3 Orestes Vicente Forlenza2 1Department of Mental Health, National Institute of Science and Technology – Molecular Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil; 2Laboratory of Neuroscience (LIM-27), Department and Instit...
Guardado en:
Autores principales: | Diniz BS, Machado Vieira R, Forlenza OV |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/47369025fe4b4505bef1f6babe745cab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Optimising classification of Parkinson’s disease based on motor, olfactory, neuropsychiatric and sleep features
por: Jonathan P. Bestwick, et al.
Publicado: (2021) -
A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD
por: A. Castrioto, et al.
Publicado: (2020) -
Antiphospholipid syndrome presenting as progressive neuropsychiatric disorders: two case reports
por: Li CH, et al.
Publicado: (2013) -
Emerging role of lysosomal calcium store as a hub of neuroprotection
por: Valentina Tedeschi, et al.
Publicado: (2022) -
Acute neuropsychiatric disorders in adolescents and young adults with Down syndrome: Japanese case reports
por: Akahoshi K, et al.
Publicado: (2012)